Fidelity Investments
HCAT icon

Fidelity Investments’s Health Catalyst HCAT Stock Holding History

Fidelity Investments’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$467K Buy
367,473
+18,757
+5% +$35.3K ﹤0.01% 3158
2025
Q4 		$833K Buy
348,716
+75,783
+28% +$207K ﹤0.01% 2920
2025
Q3 		$778K Buy
272,933
+13,072
+5% +$44.7K ﹤0.01% 2885
2025
Q2 		$980K Buy
259,861
+22,810
+10% +$89.7K ﹤0.01% 2726
2025
Q1 		$1.07M Buy
237,051
+6,340
+3% +$33.5K ﹤0.01% 2654
2024
Q4 		$1.63M Buy
230,711
+19,103
+9% +$152K ﹤0.01% 2505
2024
Q3 		$1.72M Buy
211,608
+45,902
+28% +$332K ﹤0.01% 2441
2024
Q2 		$1.06M Buy
165,706
+81,875
+98% +$526K ﹤0.01% 2504
2024
Q1 		$631K Buy
83,831
+5,231
+7% +$47.7K ﹤0.01% 2649
2023
Q4 		$728K Sell
78,600
-1,339
-2% -$10.9K ﹤0.01% 2560
2023
Q3 		$809K Sell
79,939
-13,580
-15% -$162K ﹤0.01% 2502
2023
Q2 		$1.17M Sell
93,519
-160,623
-63% -$1.91M ﹤0.01% 2449
2023
Q1 		$2.97M Buy
254,142
+61,627
+32% +$786K ﹤0.01% 2259
2022
Q4 		$2.05M Buy
192,515
+137,627
+251% +$1.33M ﹤0.01% 2368
2022
Q3 		$532K Sell
54,888
-33,879
-38% -$449K ﹤0.01% 2764
2022
Q2 		$1.29M Sell
88,767
-2,861,491
-97% -$48.8M ﹤0.01% 2616
2022
Q1 		$77.1M Sell
2,950,258
-4,476,328
-60% -$127M 0.01% 1194
2021
Q4 		$294M Sell
7,426,586
-13,364
-0.2% -$609K 0.02% 650
2021
Q3 		$372M Buy
7,439,950
+811,839
+12% +$44.3M 0.03% 544
2021
Q2 		$368M Buy
6,628,111
+1,803,883
+37% +$96.1M 0.03% 570
2021
Q1 		$226M Buy
4,824,228
+2,723,593
+130% +$132M 0.02% 737
2020
Q4 		$91.4M Buy
2,100,635
+1,024,776
+95% +$37.8M 0.01% 1074
2020
Q3 		$39.4M Buy
1,075,859
+541,212
+101% +$18.4M ﹤0.01% 1285
2020
Q2 		$15.6M Sell
534,647
-554,187
-51% -$15.3M ﹤0.01% 1646
2020
Q1 		$28.5M Buy
1,088,834
+77,192
+8% +$2.36M ﹤0.01% 1259
2019
Q4 		$35.1M Sell
1,011,642
-143,642
-12% -$4.75M ﹤0.01% 1369
2019
Q3 		$36.6M Buy
+1,155,284
New +$45.5M ﹤0.01% 1326

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments's HCAT Position: Q1 2026 in Review

Fidelity Investments increased its Health Catalyst (HCAT) stake by 5.4% in Q1 2026, buying an estimated $35.3K and bringing the position to 367,473 shares worth $467K. The position accounts for ﹤0.01% of the portfolio, ranked #3158.

Fidelity Investments first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $372M in Q3 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Fidelity Investments held 367,473 shares of Health Catalyst worth $467K as of Q1 2026.
  • Fidelity Investments bought 18,757 Health Catalyst shares in Q1 2026, an estimated $35.3K.
  • Health Catalyst made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #3158 holding.
  • Fidelity Investments first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Fidelity Investments's Health Catalyst position peaked at $372M in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.